Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.33 |
| ▸ | CA2 | P00918 | 4/20 | 0.33 |
| ▸ | CA7 | P43166 | 4/20 | 0.33 |
| ▸ | CA9 | Q16790 | 4/20 | 0.33 |
| ▸ | CA12 | O43570 | 3/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | G6PD | P11413 | 1/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.33 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2955217 | 0.86 | CA2 (0.43) | CA1CA2CA7CA9CA12 | |
| SCHEMBL11895292 | 0.81 | CA1 (0.42) | CA1CA2CA7CA9CA12 | |
| SCHEMBL23771986 | 0.76 | HTR2A (0.38) | CA1CA2CA7CA9CA12 | |
| SCHEMBL27918526 | 0.76 | ACHE (0.38) | CA1CA2CA7CA9CA12 | |
| SCHEMBL7979038 | 0.75 | LMNA (0.37) | CA1CA2CA7CA9CA12 | |
| SCHEMBL744622 | 0.74 | TP53 (0.44) | CA1CA2KDM4EMAPTMAPK1 | |
| SCHEMBL30577021 | 0.74 | TP53 (0.44) | CA1CA2KDM4EMAPTMAPK1 | |
| Hydrochloric Acid SCHEMBL27921669 | 0.74 | CA2 (0.33) | CA1CA2CA7CA9CA12 | |
| SCHEMBL4865708 | 0.74 | NQO2 (0.39) | CA1CA2CA7CA9CA12 | |
| Hydrochloric Acid SCHEMBL27903884 | 0.74 | CA2 (0.33) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0721465-B1 | GLUTATHIONE S-TRANSFERASE-ACTIVATED COMPOUNDS | TELIK INC (US) | 2000-05-03 | — | — | EP | claimed |
| US-5556942-A | Glutathione S-transferase-activated compounds | TERRAPIN TECHNOLOGIES, INC. (US) | 1996-09-17 | — | — | US | claimed |
| US-5545621-A | Glutathione S-transferase-activated compounds | TERRAPIN TECHNOLOGIES, INC. (US) | 1996-08-13 | — | — | US | claimed |
| EP-0721465-A1 | GLUTATHIONE S-TRANSFERASE-ACTIVATED COMPOUNDS | TERRAPIN TECHNOLOGIES, INC. (US) | 1996-07-17 | — | — | EP | claimed |
| WO-1995009866-A1 | GLUTATHIONE S-TRANSFERASE-ACTIVATED COMPOUNDS | TERRAPIN TECHNOLOGIES, INC. (US) | 1995-04-13 | — | — | WO | claimed |
| WO-1995009865-A1 | GLUTATHIONE S-TRANSFERASE-ACTIVATED COMPOUNDS | TERRAPIN TECHNOLOGIES, INC. (US) | 1995-04-13 | — | — | WO | claimed |
| EP-3662996-A2 | MOLYBDENUM AND TUNGSTEN COMPLEXES AS OLEFIN METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | Verbio Vereinigte BioEnergie AG (DE) | 2020-06-10 | — | — | EP | disclosed |
| EP-2703081-B1 | MOLYBDENUM AND TUNGSTEN COMPLEXES AS OLEFIN METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | XIMO AG (CH) | 2019-08-07 | — | — | EP | disclosed |
| US-10343153-B2 | Metathesis catalysts and reactions using the catalysts | XIMO AG (CH) | 2019-07-09 | — | — | US | disclosed |
| US-9919299-B2 | Metathesis catalysts and reactions using the catalysts | XIMO AG (CH) | 2018-03-20 | — | — | US | disclosed |
| US-20160030936-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | VERBIO SE (DE) | 2016-02-04 | — | — | US | disclosed |
| EP-2969204-A2 | MOLYBDENUM AND TUNGSTEN COMPLEXES AS OLEFIN METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | XiMo AG (CH) | 2016-01-20 | — | — | EP | disclosed |
| US-20140309466-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | VERBIO SE (DE) | 2014-10-16 | — | — | US | disclosed |
| WO-2014139679-A2 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | XIMO AG (CH) | 2014-09-18 | — | — | WO | disclosed |
| EP-2703081-A1 | Molybdenum and tungsten complexes as olefin metathesis catalysts and reactions using the catalysts | XiMo AG (CH) | 2014-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10343153-B2 | Metathesis catalysts and reactions using the catalysts | MSMO1, SQLE, MOGAT2 | CA1 2101/4885CA2 3454/4885CA7 1857/4885 |
| US-20140309466-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | MSMO1, PYM1, SQLE | CA1 3824/4885CA2 3960/4885CA7 2867/4885 |
| US-20160030936-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | MSMO1, SQLE, PYM1 | CA1 3667/4885CA2 3970/4885CA7 2693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.